ELIVALDOGENE TAVALENTIVEC
UNII VI2NBA6B8C

Substance Identification & Data

This profile provides standardized clinical and technical data for Elivaldogene Tavalentivec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VI2NBA6B8C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1905397-73-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

VI2NBA6B8C

CAS Registry Number

1905397-73-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ELIVALDOGENE TAVALENTIVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C169938

National Cancer Institute reference terminology for clinical and research data.

INN ID

10074

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-145

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elivaldogene Tavalentivec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ELIVALDOGENE TAVALENTIVEC

Common Names & Synonyms

DNA (LENTIVIRAL VECTOR CLONE LENTI-D HUMAN X-LINKED ADRENOLEUKODYSTROPHY ABCD1 GENE CDNA-SPECIFYING)

ELIVALDOGENE TAVALENTIVEC [INN]

ELIVALDOGENE TAVALENTIVEC [USAN]

Systematic Nomenclature

A VSV-G*-PSEUDOTYPED SELF-INACTIVATING HIV-1-DERIVED LENTIVIRAL VECTOR (PLBP100 HALD) ENCODING HUMAN ADRENOLEUKODYSTROPHY (ALD) PROTEIN (ABCD1 GENE) UNDER THE CONTROL OF A MODIFIED MYELOPROLIFERATIVE SARCOMA VIRUS PROMOTER

SYS